Ibrutinib in Combination with Sorafenib Synergistically Inhibits Proliferation and Survival of Hepatocellular Carcinoma Cells by Targeting EGFR Signaling Pathway
2017
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI